Track Canopy Growth Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Canopy Growth Corporation CGC · Stock Open Canopy Growth Corporation in new tab

0.5612 USD
EPS
-0.51
P/B
0.55
ROE
-39.19
Beta
2.44
Canopy Growth Corporation logo

Canopy Growth Corporation

🧾 Earnings Recap – Q2 2027

Canopy’s shares fell 3.6% after earnings, with the sharp 44% year-over-year revenue decline at Storz & Bickel the clearest disclosed drag on an otherwise growing cannabis business. The call also points to a gap before cultivation improvements at Kincardine fully contribute: management expects the impact to be felt starting in fiscal 2028.

  • Consolidated net revenue rose 22% year over year to $81.4 million; cannabis revenue increased 30% to $66.2 million.
  • International cannabis revenue grew 141% year over year and 28% sequentially to $12.3 million. Canada Medical revenue rose 18% to $25.8 million, and Canada Adult Use revenue increased 17% to $21.8 million.
  • Storz & Bickel revenue fell 44% to $50.1 million. Management cited variable consumer spending and changing market trends, while expecting a seasonally stronger third quarter.
  • Canopy expects Kincardine yield and flower quality to improve noticeably exiting Q3, with the full impact beginning in fiscal 2028; it sees potential to raise production there by at least 25%–30% within the same footprint.
  • EU GMP certification at Smiths Falls creates a path to sell additional patient-ready product categories in Europe, but management said it is still working with channels and expects to provide updates in future quarters.
📅
Loading chart...
Key Metrics
EPS-0.51
Book Value1.09
Price to Book0.55
Debt/Equity37.81
% Insiders0.179%
Growth
Revenue Growth0.22%
Estimates
Forward P/E-5.00
Forward EPS-0.12

DCF valuation

Model fair value for Canopy Growth Corporation (CGC)
Result
Sign in to run the valuation for CGC.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Canopy Growth Corporation Logo Canopy Growth Corporation Analysis (CGC)

Canada Health Care Official Website Stock

Is Canopy Growth Corporation a good investment? Canopy Growth Corporation (CGC) is currently trading at 0.5612 USD.

Investor FAQ

Does Canopy Growth Corporation pay a dividend?

No, it does not currently pay a dividend.

What asset class is Canopy Growth Corporation?

Canopy Growth Corporation is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

Company Profile

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-commerce shop; medical cannabis online distribution platform; and an online medical cannabis clinic. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Abba Medix, Storz & Bickel, Wana, and Claybourne, Apollo, Canada House, R'belle, LowKey, MTL Cannabis, DeeLish, DOJA brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

Exchange Ticker
NMS (United States) CGC
TOR (Canada) WEED.TO
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Dec. 20, 2023 1:10
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion